All posts by: Michael Zand

About Michael Zand

Immunotherapy may treat deadly brain tumor – News Chief

Continue reading

2017-10-03 NEWS

Immunotherapy may treat deadly brain tumor
News Chief
GAINESVILLE — University of Florida Health researchers have found an immunotherapy approach to treat glioblastoma, the aggressive, stubborn type of brain tumor that recently afflicted Sen. John McCain. The five-year survival rate is less than 10

and more »

Continue reading

2017-10-03 NEWS

University of Virginia

As Immunotherapy Ramps Up, Chemist Wins $600000 Early Career Grant
University of Virginia
“With FDA approval of immunotherapy and clinical trials demonstrating the efficacy of this type of treatment, we are entering an exciting and highly promising era for the precise, targeted treatment of cancers and other life-threatening diseases,” Hsu

Continue reading

2017-10-03 NEWS

University of Virginia

As Immunotherapy Ramps Up, Chemist Wins $600000 Early Career Grant
University of Virginia
“With FDA approval of immunotherapy and clinical trials demonstrating the efficacy of this type of treatment, we are entering an exciting and highly promising era for the precise, targeted treatment of cancers and other life-threatening diseases,” Hsu

Continue reading

2017-10-03 NEWS

Gene therapy shows promise for bladder cancer subtype
Healio
“Recombinant adenovirus interferon alfa gene therapy is a breakthrough opportunity … because it is formulated to allow the adenovirus to penetrate the cells that line the bladder,” Dinney said. “Once in the cells, the gene it contains causes